15 May 2023 - Before 1962, US federal law did not require pre-marketing proof of effectiveness for drugs. But senate hearings revealing widespread false advertising of drugs—along with the thalidomide safety disaster—spurred Congress into action.
From then on, approval of a new drug application by the US FDA required proof of “substantial evidence” of effectiveness.